Overview Research Programs Shared Facilities News & Outreach Technology Transfer Employment About PHRI

 
 
 

March 14, 2018: Students, faculty and staff in solidarity with Florida shooting victims and all who have suffered from gun violence


  PHRI



Faculty Positions in Infectious Disease Research

 
The Public Health Research Institute (PHRI; www.phri.org) of New Jersey Medical School, Rutgers Biomedical and Health Sciences, located in Newark, New Jersey, is recruiting two faculty members at the Assistant, Associate and Full Professor levels. PHRI is a leading infectious disease research center that emphasizes basic and translational sciences. Candidates must have a Ph.D. and/or an M.D. and a founded research program addressing critical questions in fungal, bacterial or viral biology and/or host responses. Concurrent active clinical practice will also be highly regarded. Preference will be given to programs focused on respiratory infections. PHRI is housed in a state of the art research facility that has extensive core services, including a nationally designated BSL3 laboratory and animal facilities. PHRI offers a robust and highly collegial research environment, generous start-up founds, and a comprehensive benefits package. Candidates should submit a curriculum vitae, a statement of research interests and accomplishments, and at least four references.

To apply visit www.jobs.rutgers.edu, Posting number 18FA0109. Any questions should be sent to Dr. Gloria Marcela Rodriguez, Chair Recruitment Committee, Public Health Research Institute, New Jersey Medical School, Rutgers Biomedical Health Sciences. Tel: (973) 854-3262; Email: rodrigg2@njms.rutgers.edu

Rutgers, the State University of New Jersey, is an Equal Opportunity/Affirmative Action employer, and is compliant with the Americans with disabilities Act (ADA). For more information, please visit www.recruitment.rutgers.edu. Women and minorities are encouraged to apply.




   
  
 
  09.27.18   www.finddx.org: Press Release: Call for trial partners now open to advance evaluation of an innovative, sensitive point-of care test that detects tuberculosis in HIV-positive people
  09.26.18   www.nejm.org: Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
  09.24.18   www.find.com: United to end tuberculosis: an urgent global response to a global epidemic
  09.11.18   www.nexus.od.nih.gov: Funding Longevity by Gender Among NIH-Supported Investigators
  09.10.18   www.mdlinx.com: Incidence of tickborne diseases doubles in the US: What you need to know
  07.23.18   www.startribune.com: A troubling exit: Drug company ends antibiotics research
  07.11.18   www.mdlinx.com: How Mycobacterium tuberculosis escapes death in macrophages
  07.06.18   www.cidrap.umn.edu: CDC profiles outbreaks linked to untreated recreational water


 
    
  10.10.18   Dr. Abraham Pinter has been part of an ongoing study led by The Foundation for Innovative New Diagnostics (FIND) to develop a fast diagnotic test to detect tuberculosis in people infected with HIV. For details, visit www.rutgers.edu.
    
  08.30.18   EurekAlert posted a press release entitled "How damaging immune cells develop during tuberculosis" on a research article from Marila Gennaro's group published in PLOS Pathogens. For details, visit www.eurekalert.org and www.journals.plos.org
    
  08.27.18   A Postdoctoral position is available in the laboratory of Dr. Bushkin. Visit Employment Opportunities for details.
    
  07.11.18   PHRI is proud to announce that Drs. Jyothi Nagajyothi and Gloria Marcela Rodriguez were promoted to Associate Professors at New Jersey Medical School.
    


 


Follow us on:    
 
     Copyright © 2018 All rights reserved.   PHRI at ICPH 225 Warren St. Newark, NJ 07103-3535 TEL 973 854 3100, FAX 973 854 3101